Gene: CCNE1
Official Full Name: cyclin E1provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK2, whose activity is required for cell cycle G1/S transition. This protein accumulates at the G1-S phase boundary and is degraded as cells progress through S phase. Overexpression of this gene has been observed in many tumors, which results in chromosome instability, and thus may contribute to tumorigenesis. This protein was found to associate with, and be involved in, the phosphorylation of NPAT protein (nuclear protein mapped to the ATM locus), which participates in cell-cycle regulated histone gene expression and plays a critical role in promoting cell-cycle progression in the absence of pRB. [provided by RefSeq, Apr 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01690 | CCNE1 Knockout cell line (HeLa) | Human | CCNE1 | 1:3~1:6 | Negative | Online Inquiry |
KO01691 | CCNE1 Knockout cell line (HCT 116) | Human | CCNE1 | 1:2~1:4 | Negative | Online Inquiry |
KO01692 | CCNE1 Knockout cell line (HEK293) | Human | CCNE1 | 1:3~1:6 | Negative | Online Inquiry |
KO01693 | CCNE1 Knockout cell line (A549) | Human | CCNE1 | 1:3~1:4 | Negative | Online Inquiry |
CCNE1 Gene Knockout Cell Lines are specialized biological tools that facilitate the study of the cyclin E1 gene (CCNE1) by completely disrupting its function in cellular models. The CCNE1 gene plays a critical role in cell cycle regulation, particularly in the G1 to S phase transition. By generating knockout variants of cell lines, researchers can explore the consequences of CCNE1 loss on cellular behavior, including proliferation, differentiation, and response to pharmacological interventions.
The mechanistic basis of these cell lines involves CRISPR-Cas9 technology or other gene editing methods, which target specific sequences within the CCNE1 gene to induce frameshift mutations. This disruption alters the normal physiological function of CCNE1, allowing scientists to investigate related pathways and uncover its role in oncogenesis, where dysregulation of cell cycle genes is prevalent. These knockout cell lines serve as essential models for understanding cancer biology, providing insights into tumor development and potential therapeutic targets.
From a scientific perspective, the CCNE1 Gene Knockout Cell Lines are invaluable for researchers exploring cellular responses to drugs or studying cell cycle dynamics under various conditions. In clinical settings, such models can inform the design of targeted therapies, aiding in the development of more effective cancer treatments tailored to specific genetic profiles.
What sets these knockout cell lines apart from alternatives is their rigorously validated knockout efficiency and specificity, ensuring reliable and reproducible results across diverse experimental paradigms. Additionally, these cell lines come with the support of detailed characterization data to facilitate immediate implementation into ongoing research.
In conclusion, investing in CCNE1 Gene Knockout Cell Lines provides researchers and clinicians with unparalleled tools for advancing our understanding of cell cycle regulation and cancer biology. Our company has a rich history of expertise in producing high-quality biological research products, enabling seamless integration of these innovative models into your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.